Schwarz, Lena A.
Dotter, Christoph P. https://orcid.org/0000-0002-9033-9096
Isaev, Sergey https://orcid.org/0000-0002-0404-9261
Lisi, Michela https://orcid.org/0000-0003-0360-4777
Malzl, Daniel https://orcid.org/0000-0001-5765-6375
Büschl, Christoph https://orcid.org/0000-0003-1729-9785
Ladstätter, Sabrina https://orcid.org/0000-0001-5773-5436
Oliveira, Bárbara
Barel, Matteo https://orcid.org/0000-0002-2894-8608
Basilico, Bernadette https://orcid.org/0000-0003-1843-3173
Chintaluri, Chaitanya https://orcid.org/0000-0003-4252-1608
Gorkiewicz, Sarah https://orcid.org/0009-0008-1567-8398
Goudarzi, Mohammad
Belinova, Tereza https://orcid.org/0000-0001-7304-4758
Reichl, Stephan https://orcid.org/0000-0001-8555-7198
Sendžikaitė, Gintarė https://orcid.org/0000-0003-4569-3472
Jayaram, Satish Arcot https://orcid.org/0000-0002-2479-2669
Koppensteiner, Peter https://orcid.org/0000-0002-3509-1948
Sommer, Christoph https://orcid.org/0000-0003-1216-9105
Vogels, Tim P. https://orcid.org/0000-0003-3295-6181
Menche, Jörg https://orcid.org/0000-0002-1583-6404
Adameyko, Igor https://orcid.org/0000-0001-5471-0356
Kharchenko, Peter V. https://orcid.org/0000-0002-6036-5875
Bock, Christoph https://orcid.org/0000-0001-6091-3088
Novarino, Gaia https://orcid.org/0000-0002-7673-7178
Article History
Received: 24 July 2024
Accepted: 18 May 2026
First Online: 17 June 2026
Competing interests
: G.N. is a founder and scientific advisor of Neurolentech, Solgate and Cellgate. C. Bock is a cofounder and scientific advisor of Myllia Biotechnology and Neurolentech. The other authors declare no competing interests.